Pulmonary Embolism Without Deep Venous Thrombosis

Schwartz T, Hingorani A, Ascher E, et al (Maimonides Med Ctr, Brooklyn, NY) Ann Vasc Surg 26:973-976, 2012^§

Abstract

Background

To identify patients with pulmonary embolism (PE) without deep venous thrombosis (DVT), and to compare them with those with an identifiable source on upper (UED) and lower-extremity venous duplex scans (LED).

Methods

We performed a retrospective review of 2700 computed tomography angiograms of the chest between January 2008 and September 2010 and identified 230 patients with PE. We then evaluated the results of UED and LED and divided the patients into four groups based on the results of their duplex studies. We compared patients with PE and DVT with those with PE and no DVT in terms of age, gender, size and location of PE, critical illness, malignancy, and in-hospital mortality.

Results

We identified 152 women and 78 men (mean age, 68 years) with PE. One hundred thirty-one patients had a documented source of PE (group 1). Fifty-three patients had negative LED results, but did not undergo UED (group 2). Thirty-one patients did not undergo either LED or UED (group 3). Seven men and eight women had no documented source of PE on UED and LED (group 4). Ten of 15 patients in group 4 had a documented malignancy listed as one of their diagnoses. Because patients in groups 2 and 3 did not undergo complete duplex studies, we excluded them from our analysis. We then reviewed the discharge summaries of patients in groups 1 and 4. There was no statistically significant difference in age and gender distribution, size and location of PE, critical illness, smoking status, cardiovascular disease, trauma, and in-hospital mortality between patients in group 1 and 4. Patients in group 4 had a statistically significant increased prevalence of malignancy (67% vs. 40%, P = 0.046). Patients in group 4 also had a higher percentage of active cancer than those in group 1 (47% vs. 24%, P = 0.084), although not statistically significant. We defined active cancer as either a metastatic disease or a malignancy diagnosed shortly before or after the diagnosis of PE. Patients who were undergoing treatment for cancer at the time of diagnosis of PE were also considered to have active cancer.

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

1. Muscle Adaptation in Response to Supervised Exercise Training for Intermittent Claudication
2. Follow-Up of Endovascular Treatment for Trans-Atlantic Inter-Society Consensus II Type B Iliac Lesions in Patients Aged <50 Years
3. of Gender and Age on Outcomes of Tibial Artery Endovascular Interventions in Critical Limb Ischemia
4. of Descending Aortic Pathology and Evaluation of the Impact of Thoracic Endovascular Aortic Repair: A Population-based Study in England and Wales from 1999 to 2010

Stay updated, free articles. Join our Telegram channel

Join